Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
about
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysisCommon medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Cardiovascular safety of anti-diabetic drugsThe Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical TrialsDifferential pharmacology and clinical utility of empagliflozin in type 2 diabetesUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic reviewInsulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulatorsManagement standards for stable coronary artery disease in India.Management Protocols of stable coronary artery disease in India: Executive summary.Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes MellitusRisk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet.Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis.Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Cardiovascular safety profile of currently available diabetic drugs.Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 CascadeDissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span.Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident strokeMetformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.Longitudinal Patterns of Blood Pressure, Incident Cardiovascular Events, and All-Cause Mortality in Normotensive Diabetic PeopleNew insights into insulin action and resistance in the vasculature.Type 2 diabetes and cardiovascular disease: what next?Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity.Translating the Science of Aging into Therapeutic Interventions.Metformin: A Hopeful Promise in Aging Research.Cardiovascular effects of anti-diabetes drugs.Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet.Long-term studies of treatments for type 2 diabetes.The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.Interpreting Cardiovascular Endpoints in Trials of Antihyperglycemic Drugs.A review on cardiovascular effects of newer hypoglycaemic medications.Effects of glucose-lowering agents on ischemic stroke.The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
P2860
Q22241119-2454A2A3-A05C-4E9A-8CA0-5D41B63AB2E7Q26740253-43307C7E-BFA2-4844-8268-ACAF282F721FQ26741082-B47D5AFC-2F30-4B10-B280-FF04473981E5Q26748870-A6652ACD-5447-458B-B7AB-6807EA83533DQ26749281-5503E621-FCCF-44F0-8D0B-E36E9B5E4735Q27687851-53C3D2C2-55C4-428A-8D42-FBB5DCAC4011Q28071386-C57ABA75-399A-4533-8D6D-5DB5B1238455Q28081458-6C85F9F1-EB04-42C3-8ED8-A78721D59656Q30239853-C29DF804-D0AC-4E1C-A22D-014287F13A5DQ30240155-857F733B-2B8D-427A-A0D4-545E49E778E6Q33618721-AC76A0BB-B253-4639-968D-67B4CC77BE38Q33705903-A5D86DBE-C0A7-4816-B7E3-44002D59BE5EQ33708461-61B0E3A6-8039-48EB-AB9F-5FA26E7D875AQ33727891-C0354819-5E0E-449F-B8AB-7408294091B5Q33815573-E3119CB1-3CD3-4BFC-B9AD-58054195C397Q34971736-A94B954C-0F41-4BED-93BC-0DD8D0101A1CQ35044151-E2E785D7-7B9C-4DB8-A97C-4517D5043804Q35961020-DBF7206F-0FD4-4921-8D73-CEACC1F9BE7AQ36406255-944E4863-9285-4817-8B81-3B32BE467529Q36520595-F419F2A0-BD57-4001-95C8-FBA5A0203C3AQ36836016-B90F7BF6-A42A-4123-ABF0-2D032D558AB0Q37170469-36F81644-2DC9-478B-A005-5E41BFDA40CEQ37707789-6F970057-54FC-47C8-A548-48C2226D5756Q38191133-91DC6C82-7139-41D8-B92A-B9AE298DFA89Q38364806-0E7433EE-0386-4166-BC1F-EBA3638BB676Q38377128-DEECCF03-806F-4710-ACAA-6A64AFA98B50Q38524435-CBF1BBED-C238-4BE2-8068-89736DE48B6BQ38644587-1DBF6591-6C4D-401C-B301-2170B47B1D78Q38737909-1995B7A7-BA42-4F45-BC77-7804B2F3FC35Q38756902-4DF0BE0F-EEC9-4FD3-9261-877355175F8DQ38756907-183DC9E7-892B-4011-B9BC-BF50EF6F4553Q38857056-13BDD555-4143-437E-8F2F-71C8F9CE542BQ39000136-D7465493-C3B9-4AB0-91A7-9553C46C8812Q39018646-74999F4E-0948-41FC-A8E9-E6E278A9DD70Q39123582-D1858E0C-0223-4D7C-9B06-9533BA4E78FDQ39136054-7EDE3A31-DCE5-46F0-8AE6-A022120F63D5Q39328296-9DDC1323-3B76-4E53-9D21-BA88BC2177A0Q39427199-A6AF57F1-454E-481E-A18F-2ACC91016C6BQ40842440-F521D20B-78B0-4273-9F65-E0323B2FDAF1Q40844288-BE1501E8-AC2B-4B6A-87C0-D4F237F39CBC
P2860
Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of metformin versus gl ...... s and coronary artery disease.
@en
type
label
Effects of metformin versus gl ...... s and coronary artery disease.
@en
prefLabel
Effects of metformin versus gl ...... s and coronary artery disease.
@en
P2093
P2860
P921
P356
P1433
P1476
Effects of metformin versus gl ...... s and coronary artery disease.
@en
P2093
Dalong Zhu
Dawang Wang
Guang Ning
Guoting Wu
Jiajun Zhao
P2860
P304
P356
10.2337/DC12-0719
P407
P577
2012-12-10T00:00:00Z